Wegovy, India’s first injectable semaglutide for chronic weight management, recorded Rs 2.54 crore in sales in June ...

Some people on Mounjaro injections experience sulfur burps or egg burps, caused by delayed gastric emptying. The longer food ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years ...

A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole authority to recognise the future reincarnation, ending years of waiting by ...

For people who constantly think about what they are going to eat meal to meal, their food noise goes down significantly’ ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

As obesity management draws awareness and weight-loss injections are launched in India, hospitals are offering customised ...

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

LLY has slid 15.7% over the past year, but surging demand for Mounjaro and Zepbound could revive the stock's momentum.

In India's rapidly growing anti-obesity drug landscape, Mounjaro (tirzepatide), launched by Eli Lilly in March 2025, is ...

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising ...